{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:01:02Z","timestamp":1777309262671,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","award":["K23DK129827"],"award-info":[{"award-number":["K23DK129827"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jcte.2025.100421","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:48:26Z","timestamp":1760806106000},"page":"100421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Alternative approaches to glucose measurements during oral glucose tolerance testing in youth with cystic fibrosis: a mixed methods pilot study"],"prefix":"10.1016","volume":"42","author":[{"given":"Seema","family":"Meighan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Gallop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa S.","family":"Putman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-9774","authenticated-orcid":false,"given":"Brynn E.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2025.100421_b0005","unstructured":"Cystic Fibrosis Foundation. 2023 Cystic Fibrosis Foundation Patient Registry 2023. https:\/\/www.cff.org\/media\/34491\/download."},{"issue":"7\u20138","key":"10.1016\/j.jcte.2025.100421_b0010","first-page":"449","article-title":"Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study","volume":"24","author":"Kolouskova","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jcte.2025.100421_b0015","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcte.2025.100421_b0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000110206","article-title":"Long-term effect of insulin treatment in cystic fibrosis-related diabetes","volume":"76","author":"Mohan","year":"2008","journal-title":"Respiration"},{"issue":"12","key":"10.1016\/j.jcte.2025.100421_b0025","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jcte.2025.100421_b0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcf.2019.07.010","article-title":"The association of pediatric cystic fibrosis-related diabetes screening on clinical outcomes by center: a CF patient registry study","volume":"19","author":"Franck Thompson","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"24","key":"10.1016\/j.jcte.2025.100421_b0035","doi-asserted-by":"crossref","DOI":"10.3310\/hta16240","article-title":"Screening for cystic fibrosis-related diabetes: a systematic review","volume":"16","author":"Waugh","year":"2012","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1016\/j.jcte.2025.100421_b0040","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1108\/IJHCQA-05-2014-0059","article-title":"Improving screening for diabetes in cystic fibrosis","volume":"28","author":"Abdulhamid","year":"2015","journal-title":"Int J Health Care Qual Assur"},{"issue":"2","key":"10.1016\/j.jcte.2025.100421_b0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MCP.0000000000000244","article-title":"The psychological burden of cystic fibrosis","volume":"22","author":"Quittner","year":"2016","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.jcte.2025.100421_b0050","first-page":"100","article-title":"Patient and parent perceptions of the diagnosis and management of cystic fibrosis-related diabetes","volume":"1","author":"Millington","year":"2014","journal-title":"J Clin Transl Endocrinol"},{"issue":"7","key":"10.1016\/j.jcte.2025.100421_b0055","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/dme.13961","article-title":"Performance evaluation of a self-administered home oral glucose tolerance test kit in a controlled clinical research setting","volume":"36","author":"Dunseath","year":"2019","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.jcte.2025.100421_b0060","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2337\/dc12-0643","article-title":"Evaluation of a self-administered oral glucose tolerance test","volume":"36","author":"Bethel","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.jcte.2025.100421_b0065","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1210\/jc.2014-3612","article-title":"Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth","volume":"100","author":"Chan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jcte.2025.100421_b0070","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.2337\/dc19-1690","article-title":"Lessons from continuous glucose monitoring in youth with pre-type 1 diabetes, obesity, and cystic fibrosis","volume":"43","author":"Chan","year":"2020","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcte.2025.100421_b0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/pedi.12910","article-title":"Estimating plasma glucose with the FreeStyle Libre pro continuous glucose monitor during oral glucose tolerance tests in youth without diabetes","volume":"20","author":"Ghane","year":"2019","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"10.1016\/j.jcte.2025.100421_b0080","doi-asserted-by":"crossref","first-page":"e1444","DOI":"10.1210\/clinem\/dgab857","article-title":"Continuous glucose monitoring and HbA1c in cystic fibrosis: clinical correlations and implications for CFRD diagnosis","volume":"107","author":"Scully","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jcte.2025.100421_b0085","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1210\/clinem\/dgab692","article-title":"The relationship between continuous glucose monitoring and OGTT in youth and young adults with cystic fibrosis","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jcte.2025.100421_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.ede.0000147512.81966.ba","article-title":"Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples","volume":"16","author":"Schisterman","year":"2005","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.jcte.2025.100421_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1076-6332(96)80451-X","article-title":"Comparison of receiver operating characteristic curves on the basis of optimal operating points","volume":"3","author":"Halpern","year":"1996","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.jcte.2025.100421_b0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1207\/S15328031US0204_01","article-title":"Determination and interpretation of the optimal operating point for ROC Curves derived through generalized linear models","volume":"2","author":"Gallop","year":"2003","journal-title":"Understanding Statistics"},{"key":"10.1016\/j.jcte.2025.100421_b0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qualit Res Psychol"},{"issue":"8","key":"10.1016\/j.jcte.2025.100421_b0120","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"10.1016\/j.jcte.2025.100421_b0125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/archdischild-2017-314250","article-title":"Continuous glucose monitoring to evaluate glycaemic abnormalities in cystic fibrosis","volume":"103","author":"Zorron Mei Hsia","year":"2018","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.jcte.2025.100421_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcf.2024.07.018","article-title":"Association of race and ethnicity with the development of cystic fibrosis-related diabetes","volume":"24","author":"Rayas","year":"2025","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623725000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623725000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:34:57Z","timestamp":1764779697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623725000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S2214623725000390"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2025.100421","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative approaches to glucose measurements during oral glucose tolerance testing in youth with cystic fibrosis: a mixed methods pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2025.100421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100421"}}